These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 21733087)

  • 1. Minimal hepatic encephalopathy does not impair health-related quality of life in patients with cirrhosis: a prospective study.
    Wunsch E; Szymanik B; Post M; Marlicz W; Mydłowska M; Milkiewicz P
    Liver Int; 2011 Aug; 31(7):980-4. PubMed ID: 21733087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Previous overt hepatic encephalopathy rather than minimal hepatic encephalopathy impairs health-related quality of life in cirrhotic patients.
    Moscucci F; Nardelli S; Pentassuglio I; Pasquale C; Ridola L; Merli M; Riggio O
    Liver Int; 2011 Nov; 31(10):1505-10. PubMed ID: 22093325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Assessment of the health-related quality of life of patients with minimal hepatic encephalopathy].
    Bo ZJ; Qiu DK; Ma X; Zhang GS; Fan ZP; Huang YQ; Yu XF; Zeng MD
    Zhonghua Gan Zang Bing Za Zhi; 2007 Jun; 15(6):412-6. PubMed ID: 17594803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normalization of the psychometric hepatic encephalopathy score in Polish population. A prospective, quantified electroencephalography study.
    Wunsch E; Koziarska D; Kotarska K; Nowacki P; Milkiewicz P
    Liver Int; 2013 Oct; 33(9):1332-40. PubMed ID: 23651263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life in cirrhosis is related to potentially treatable factors.
    Les I; Doval E; Flavià M; Jacas C; Cárdenas G; Esteban R; Guardia J; Córdoba J
    Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):221-7. PubMed ID: 19794311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In patients with liver cirrhosis, proinflammatory interleukins correlate with health-related quality of life irrespective of minimal hepatic encephalopathy.
    Wunsch E; Koziarska D; Milkiewicz M; Naprawa G; Nowacki P; Hartleb M; Milkiewicz P
    Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1402-7. PubMed ID: 24025977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simplified psychometric evaluation for the diagnosis of minimal hepatic encephalopathy.
    Riggio O; Ridola L; Pasquale C; Pentassuglio I; Nardelli S; Moscucci F; Merli M; Montagnese S; Amodio P; Merkel C
    Clin Gastroenterol Hepatol; 2011 Jul; 9(7):613-6.e1. PubMed ID: 21440091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of critical flicker frequency and psychometric hepatic encephalopathy score in diagnosis of low-grade hepatic encephalopathy.
    Kircheis G; Hilger N; Häussinger D
    Gastroenterology; 2014 Apr; 146(4):961-9. PubMed ID: 24365582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychometric hepatic encephalopathy score for the detection of minimal hepatic encephalopathy in Korean patients with liver cirrhosis.
    Seo YS; Yim SY; Jung JY; Kim CH; Kim JD; Keum B; An H; Yim HJ; Lee HS; Kim CD; Ryu HS; Um SH
    J Gastroenterol Hepatol; 2012 Nov; 27(11):1695-704. PubMed ID: 22743001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extrapyramidal signs predict the development of overt hepatic encephalopathy in patients with liver cirrhosis.
    Compañy L; Zapater P; Pérez-Mateo M; Jover R
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):519-25. PubMed ID: 20010298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective evaluation of the impact of covert hepatic encephalopathy on quality of life and sleep in cirrhotic patients.
    Labenz C; Baron JS; Toenges G; Schattenberg JM; Nagel M; Sprinzl MF; Nguyen-Tat M; Zimmermann T; Huber Y; Marquardt JU; Galle PR; Wörns MA
    Aliment Pharmacol Ther; 2018 Aug; 48(3):313-321. PubMed ID: 29863286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-nitro-tyrosine as a peripheral biomarker of minimal hepatic encephalopathy in patients with liver cirrhosis.
    Montoliu C; Cauli O; Urios A; ElMlili N; Serra MA; Giner-Duran R; González-Lopez O; Del Olmo JA; Wassel A; Rodrigo JM; Felipo V
    Am J Gastroenterol; 2011 Sep; 106(9):1629-37. PubMed ID: 21483460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Night-time sleep disturbance does not correlate with neuropsychiatric impairment in patients with cirrhosis.
    Montagnese S; Middleton B; Skene DJ; Morgan MY
    Liver Int; 2009 Oct; 29(9):1372-82. PubMed ID: 19686311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose.
    Sharma P; Sharma BC; Agrawal A; Sarin SK
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1329-35. PubMed ID: 22606978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of preoperative overt hepatic encephalopathy on neurocognitive function after liver transplantation.
    Sotil EU; Gottstein J; Ayala E; Randolph C; Blei AT
    Liver Transpl; 2009 Feb; 15(2):184-92. PubMed ID: 19177446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Falls and cognitive dysfunction impair health-related quality of life in patients with cirrhosis.
    Román E; Córdoba J; Torrens M; Guarner C; Soriano G
    Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):77-84. PubMed ID: 22954704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and evaluation of the quality of life instrument in chronic liver disease patients with minimal hepatic encephalopathy.
    Zhou YQ; Chen SY; Jiang LD; Guo CY; Shen ZY; Huang PX; Wang JY
    J Gastroenterol Hepatol; 2009 Mar; 24(3):408-15. PubMed ID: 19054261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral glutamine challenge improves the performance of psychometric tests for the diagnosis of minimal hepatic encephalopathy in patients with liver cirrhosis.
    Irimia R; Stanciu C; Cojocariu C; Sfarti C; Trifan A
    J Gastrointestin Liver Dis; 2013 Sep; 22(3):277-81. PubMed ID: 24078984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy.
    Prasad S; Dhiman RK; Duseja A; Chawla YK; Sharma A; Agarwal R
    Hepatology; 2007 Mar; 45(3):549-59. PubMed ID: 17326150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of depressive symptoms and hepatic encephalopathy on health-related quality of life in cirrhotic hepatitis C patients.
    Barboza KC; Salinas LM; Sahebjam F; Jesudian AB; Weisberg IL; Sigal SH
    Metab Brain Dis; 2016 Aug; 31(4):869-80. PubMed ID: 27032930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.